Caffeine, by abrogating lipopolysaccharide-induced oxidative stress and neuroinflammation [61], inhibiting adenosine A2A receptor activation, reducing tau hyperphosphorylation, and accumulation of misfolded proteins is reported to provide beneficial effects in PD and AD cases [62]. This evidence concerns the gene MAPT and Alzheimer disease.